VC005
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for VC005, covering 2024-07-29 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis [Phase 2]